July 27, 2020 The Lupus Research Alliance congratulates 2018 Lupus Insight Prize recipient Betty Diamond, MD and the Feinstein Institutes for Medical Research on being awarded $15 million from the National Institute of Allergy and Infectious Disease to study brain dysfunction linked to lupus. Dr. Diamond will use the five-year grant to study a receptor […] READ MORE
July 27, 2020 A new international study published in Annals of the Rheumatic Diseases showed that belimumab (Benlysta) was safe and effective when given intravenously to children. In this Phase 2, randomized, placebo-controlled, blinded study, 93 patients 5-17 years of age received standard therapy plus either placebo or belimumab. As measured by commonly used tools, […] READ MORE
July 30, 2020 Click here to view the replay of our recent Kickoff to the 2020 ManyOne Can Walk with Us to Cure Lupus presented by GSK. Hosted by Lupus Research Alliance’s President Ken Farber, this FUNd-raising Zoom webcast featured seasoned Walk Captains who gave lots of great ideas for team building and FUNdraising, in […] READ MORE
NEW YORK, NY. July 22. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA filing and priority review designation by the U.S. Food and Drug Administration for its investigational drug voclosporin for lupus nephritis. A serious inflammation of the kidneys, lupus nephritis is one of the most common complications of systemic […] READ MORE
NEW YORK, NY. July 14 — The Lupus Research Alliance (LRA) is pleased to announce the recipients of the inaugural LRA-BMS Accelerator Award*, a collaborative project with sponsoring partner Bristol Myers Squibb. The Award provides a collective total of $3,000,000 to support ten cutting-edge lupus research projects over two years that focus on understanding […] READ MORE
Enthusiastic … charming … exuberant-these are qualities Lauren Maley has in spades-so much so that you might not easily grasp the extent to which lupus has impacted her young life. Officially she has been coping with lupus for the past five years-but in reality, it has been much longer. A false-negative lupus test resulted in […] READ MORE
When it comes to solving the mysteries of lupus, we must explore all potential avenues of discovery—including the brain. This is why the LRA is funding important research and a clinical trial to address neuropsychiatric lupus—the wide range of symptoms involving the brain that can vary from “brain fog” to stroke to psychosis. We’re also […] READ MORE
Lupus Awareness Month Although this past May—Lupus Awareness Month—wasn’t quite like others, the LRA has initiated efforts for people with lupus to connect. To help our community cope with the effects of COVID-19 in May and beyond, the LRA has unveiled a series of enlighteningly educational videos hosted by Shayla Shorter, PhD. The Learning from […] READ MORE
The challenge of finding more effective treatments for lupus-according to Dr. Fabienne Mackay, PhD-lies in the nature of the disease itself. “Lupus is not one disease, but rather a set of syndromes in which no one treatment will work for all,” she explains. With the objective to develop treatments that target the underlying disease pathways […] READ MORE
In August of 2019, the LRA had the great fortune to form a unique new partnership with Bristol Myers Squibb (formerly Celgene Corporation) -in the creation of the LRA BMS Accelerator Awards. The aim: Fast-track bold cutting-edge research projects. To get this initiative off the ground and running, the Celgene Corporation made an extraordinarily […] READ MORE
July 2, 2020 Saturday, September 12th, 2020 12:00 – 2:00 PM, EDT Register Now ► The Lupus Research Alliance is excited to announce the reimagination of our ManyOne Can. Walk with Us to Cure Lupus presented by GSK. This celebratory Walk experience will unite the entire lupus community as never before – behind one goal, on […] READ MORE
July 6, 2020 – NOTE, since this study was reported, other evidence as shown no benefit for hydroxychloroquine in treating or preventing COVID-19. A study published in the International Journal of Infectious Diseases by Henry Ford Health System found that treatment with hydroxychloroquine significantly lowered the rate of deaths among patients hospitalized with COVID-19. The […] READ MORE
